1
|
Rothe K, Rasch S, Wantia N, Poszler A, Ulrich J, Schlag C, Huber W, Schmid RM, Busch DH, Lahmer T. Aspergillus fumigatus cholangitis in a patient with cholangiocarcinoma: case report and review of the literature. Infection 2020; 49:159-164. [PMID: 32860594 PMCID: PMC7851102 DOI: 10.1007/s15010-020-01487-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2019] [Accepted: 07/21/2020] [Indexed: 11/30/2022]
Abstract
Aspergillus spp. cholangitis is an uncommon presentation of invasive aspergillosis. Only few cases are described in the literature affecting severely immunocompromised patients or patients following biliary surgery. Especially, invasive aspergillosis in non-haematological patients is associated with high mortality rates, caused by atypical presentations, which is associated with a delay in diagnosis and therapy. We report a 72-year-old man with primary diagnosis of cholangiocarcinoma and stent implantation by endoscopic retrograde cholangiopancreatography (ERCP) for biliary decompression who developed severe cholangitis with invasive aspergillosis. The patient had no history of prior hospitalisation, no immunosuppressive therapy and no preceding biliary surgery. Furthermore, in this exceptional case of extrapulmonary aspergillosis, there were no signs of pulmonary involvement. From the literature review, only three cases of Aspergillus cholangitis could be identified. Clinical manifestations of invasive aspergillosis can be variable and classical risk factors such as immunosuppression are not mandatorily present. Clinical awareness of these rare cases is of vital importance for initiation of correct therapy.
Collapse
Affiliation(s)
- Kathrin Rothe
- School of Medicine, Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany
| | - Sebastian Rasch
- School of Medicine, Department of Medicine II, Technical University of Munich, University Hospital Rechts der Isar, Ismaninger Str. 22, 81675, Munich, Germany
| | - Nina Wantia
- School of Medicine, Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany
| | - Alexander Poszler
- School of Medicine, Department of Medicine II, Technical University of Munich, University Hospital Rechts der Isar, Ismaninger Str. 22, 81675, Munich, Germany
| | - Joerg Ulrich
- School of Medicine, Department of Medicine II, Technical University of Munich, University Hospital Rechts der Isar, Ismaninger Str. 22, 81675, Munich, Germany
| | - Christoph Schlag
- School of Medicine, Department of Medicine II, Technical University of Munich, University Hospital Rechts der Isar, Ismaninger Str. 22, 81675, Munich, Germany
| | - Wolfgang Huber
- School of Medicine, Department of Medicine II, Technical University of Munich, University Hospital Rechts der Isar, Ismaninger Str. 22, 81675, Munich, Germany
| | - Roland M Schmid
- School of Medicine, Department of Medicine II, Technical University of Munich, University Hospital Rechts der Isar, Ismaninger Str. 22, 81675, Munich, Germany
| | - Dirk H Busch
- School of Medicine, Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany.,German Centre for Infection Research (DZIF), Partner site Munich, Munich, Germany
| | - Tobias Lahmer
- School of Medicine, Department of Medicine II, Technical University of Munich, University Hospital Rechts der Isar, Ismaninger Str. 22, 81675, Munich, Germany.
| |
Collapse
|